Articles

Inappropriately low hepcidin levels in patients with myelodysplastic syndrome carrying a somatic mutation of SF3B1

Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy;Department of Molecular Medicine, University of Pavia, Italy
Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK
Department of Laboratory Medicine, Laboratory of Genetic, Endocrine and Metabolic Diseases, Radboud University Nijmegen Medical Center, The Netherlands;Hepcidinanalysis.com, Nijmegen, The Netherlands
Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy;Department of Molecular Medicine, University of Pavia, Italy
Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy;Department of Molecular Medicine, University of Pavia, Italy
Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy;Department of Molecular Medicine, University of Pavia, Italy
Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy;Department of Molecular Medicine, University of Pavia, Italy
Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
Department of Diagnostic Medicine, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK
Department of Laboratory Medicine, Laboratory of Genetic, Endocrine and Metabolic Diseases, Radboud University Nijmegen Medical Center, The Netherlands;Hepcidinanalysis.com, Nijmegen, The Netherlands
Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy;Department of Molecular Medicine, University of Pavia, Italy
Vol. 98 No. 3 (2013): March, 2013 https://doi.org/10.3324/haematol.2012.077446